Anzeige
❌
Mehr »
Montag, 05.10.2026 - Börsentäglich über 12.000 News
Die Jobs, die keine KI der Welt ersetzen kann - und das Unternehmen dahinter
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLB | ISIN: FR0011049824 | Ticker-Symbol: 4ZG
Stuttgart
02.10.26 | 21:56
3,250 Euro
0,00 % 0,000
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIAN TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MEDIAN TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
3,2453,26504.10.
3,2153,26002.10.

Aktuelle News zur MEDIAN TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.09.Median Technologies Secures One of the Largest iCRO Projects in Its History382€8.4 Million global phase III oncology imaging project expands Median's iCRO order backlog and provides additional revenue visibility Regulatory News: Median Technologies (FR0011049824, ALMDT...
► Artikel lesen
10.09.Median Technologies: H2 2026 Financial Communication Calendar320Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as...
► Artikel lesen
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln
08.09.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2026458Pursuant to article L-223-8 II of the French "Code de commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
02.09.Median Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyonis Pan-Cancer Strategy554Strategic Review to Include Potential Separation of iCRO, Potential U.S. Listing and Other Strategic Alternatives The Strategic Review Committee has been tasked with evaluating a broad range...
► Artikel lesen
10.08.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2026489Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
30.07.Median Technologies and Olea Medical, a Canon Medical Systems Company, Partner to Advance Commercial Deployment of AI-Powered eyonis LCS for Lung Cancer Screening1.009Both entities have signed a global strategic commercial agreement. The agreement marks an important new step in the execution of Median's partnership-driven commercialization strategy for...
► Artikel lesen
22.07.Median Technologies Reports Record iCRO Backlog, Accelerates Commercial Rollout of eyonis LCS and Development of New Indications Across the eyonis Portfolio613Strengthened cash position at €60.8 million as of June 30, 2026, reflecting the successful €50 million capital increase completed in June 2026. Cash runway through the first half of 2028...
► Artikel lesen
15.07.Half Year Median Technologies Liquidity Contract Statement436First half of 2026 Regulatory News: Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, "Median" or "the Company") to TP ICAP (Europe), the following resources...
► Artikel lesen
06.07.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30, 2026403Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
03.07.Median Technologies' eyonis LCS Obtains CE Marking941European marketing authorization follows U.S. FDA clearance of eyonis LCS, Median's AI-based Software as a Medical Device designed to aid in the detection and diagnosis of lung cancer in screening...
► Artikel lesen
08.06.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2026396Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
03.06.Median Technologies Announces Successful Upsized Capital Increase of € 50 Million1.134Not to be published, distributed or disseminated, directly or indirectly, in the United States of America, Australia, Canada, South Africa and Japan Great Success of the capital increase with...
► Artikel lesen
01.06.Median Technologies Brings Forward Subscription Period of its €50 Million Capital Increase on the Back of Strong Demand from Institutional Investors826The €50 million capital increase, with a subscription price of €5.00 per New Share launched on May 27, 2026, is already oversubscribed The Public Offering period, initially scheduled to...
► Artikel lesen
28.05.Median Technologies: €40 Million Capital Increase Launched To Support eyonis LCS Expansion1
27.05.Median Technologies Launches a Capital Increase of €40 million, with Potential Upsize to €50 million, to Support the Deployment of eyonis LCS in the U.S. and Europe and Advance New Clinical Indications for Its Proprietary eyonis...1.069Share capital increase without shareholders' preferential subscription rights, to be carried out by way of an issue of ordinary shares in the framework of a public offering, for an amount of approximately...
► Artikel lesen
26.05.Median Technologies to Showcase iCRO's Central and AI-powered Imaging Services for Oncology Clinical Trials at ASCO 2026336Median is a leading provider of imaging services to the world's top oncology pharma companies Median will host two presentation sessions to introduce its new solutions for radiopharmaceutical...
► Artikel lesen
21.05.Median Technologies Announces the Availability of the Preparatory Documents for the Annual Shareholders' Ordinary and Extraordinary General Meeting on June 10, 2026631Regulatory News: The shareholders of Median Technologies (FR0011049824, ALMDT, "Median" or "The Company") are invited to participate in the Annual Shareholders' Ordinary and Extraordinary General...
► Artikel lesen
04.05.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30, 2026377Pursuant to article L-223-8 II of the French "Code de commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
23.04.Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights954eyonis LCS 510(k) clearance sets stage for commercialization in the United States New leadership of U.S. subsidiary and collaboration with Tempus accelerate rollout 28% reduction...
► Artikel lesen
07.04.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31, 2026472Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1